Tag: pharmaceutical exclusivity
Why Some Brand-Name Drugs Have No Generic Alternatives
Jan 15, 2026 / 10 Comments
Not all brand-name drugs have generic versions-even after patents expire. Complex formulations, patent tricks, and manufacturing hurdles keep prices high. Here's why some drugs stay expensive for years-and what you can do about it.
READ MORE
Market Exclusivity Extensions: How Pharma Extends Monopolies Beyond Patents
Jan 9, 2026 / 12 Comments
Market exclusivity extensions let drug companies block generics for years after patents expire. From orphan drug perks to pediatric bonuses, here's how pharma stretches monopolies-and why it costs billions.
READ MORERECENT POSTS
- Placebo Effect with Generics: Why Psychology Matters More Than Chemistry
- IBD Biologics Explained: Anti-TNF, Anti-Integrin, and IL-12/23 Inhibitors for Crohn's and Colitis
- How Diet Affects Allopurinol Effectiveness in Gout Management
- Market Exclusivity Extensions: How Pharma Extends Monopolies Beyond Patents
- Cozaar (Losartan) vs. Alternative Blood Pressure Drugs: Pros, Cons & Best Uses